Fang J, et al. - Experts assessed if different hepatitis B virus (HBV) infection status influenced the prognosis of patients with lupus nephritis (LN) under immunosuppressive therapy. The composite renal outcome was defined as a composite of progression to end-stage renal disease, 50% estimated glomerular filtration rate decrease, or death. As per the data, for patients with active LN, a worse prognosis could be conferred with HBV infection status. Active HBV carrier, cycle of immunosuppression > 1, and delayed immunosuppressive therapy were the 3 risk factors of the composite renal outcome.